Pros and cons of pragmatic clinical trials
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Traditional randomized controlled trials are the ‘gold standard’ for evaluating health interventions and are typically designed to maximize internal validity, often at the cost of limited generalizability. Pragmatic randomized controlled trials should be designed with a conscious effort to generate evidence with a greater external validity by making the research question as similar as possible to the questions faced by clinical decision-makers (i.e., patients and their families, physicians, policy makers and administrators) and then answer that question with rigor. Clarity and transparency about the specifics of the research question are the keys to designing, as well as interpreting, any clinical trial.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
Rothwell, P. M. (2005) · The Lancet · doi:10.1016/s0140-6736(04)17670-8 · Cited by 2,544
Improving the reporting of pragmatic trials: An extension of the CONSORT statement
Zwarenstein, M., Treweek, S., Gagnier, J. J., Altman, D. G., Tunis, S., Haynes, B., Oxman, A. D., Moher, D., & groups, F. T. C. A. P. T. I. H. (. (2008) · BMJ · doi:10.1136/bmj.a2390 · Cited by 1,813
Explanatory and pragmatic attitudes in therapeutical trials
Schwartz, D., & Lellouch, J. (1967) · Journal of Chronic Diseases · doi:10.1016/0021-9681(67)90041-0 · Cited by 1,185
A pragmatic view on pragmatic trials
Patsopoulos, N. A. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.2/npatsopoulos · Cited by 844
Large-scale randomized evidence: Large, simple trials and overviews of trials
Peto, R., Collins, R., & Gray, R. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)00150-o · Cited by 365
Research works printed but not linked: 16
- Thomas Pynchon. Gravity’s Rainbow . Viking Press Inc. NY USA (1973).
- Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. J. Clin. Epidemiol. 62(5), 499–505 (2009). · DOI · Paper page
- Sackett DL. Explanatory and pragmatic clinical trials: a primer and application to a recent asthma trial. Pol. Arch. Med. Wewn. 121(7–8), 259–263 (2011). · DOI
- Godwin M, Ruhland L, Casson I et al. Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity. BMC Med. Res. Methodol. 3, 28 (2003). · DOI · Paper page
- Thorpe KE, Zwarenstein M, Oxman AD et al. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J. Clin. Epidemiol. 62(5), 464–475 (2009). · DOI · Paper page
- Karanicolas PJ, Montori VM, Devereaux PJ, Schunemann H, Guyatt GH. A new ‘mechanistic-practical’ framework for designing and interpreting randomized trials. J. Clin. Epidemiol. 62(5), 479–484 (2009). · DOI
- Mohr P, Bitter I, Constant E et al. Myth and reality of pragmatic trials. Psychiatr. Danub. 22(1), 2–3 (2010).
- Kent DM, Kitsios G. Against pragmatism: on efficacy, effectiveness and the real world. Trials 10, 40 (2009). · DOI · Paper page
- Riddle DL, Johnson RE, Jensen MP et al. The Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) instrument was useful for refining a randomized trial design: experiences from an investigative team. J. Clin. Epidemiol. 63(11), 1271–1275 (2010). · DOI
- Schwartz D, Lellouch J. Explanatory and pragmatic attitudes in therapeutical trials. J. Chronic Dis. 20(8), 637–648 (1967). · DOI · Paper page
- Treweek S, Zwarenstein M. Making trials matter: pragmatic and explanatory trials and the problem of applicability. Trials 10, 37 (2009). · DOI · Paper page
- March J, Kraemer HC, Trivedi M et al. What have we learned about trial design from NIMH-funded pragmatic trials? Neuropsychopharmacology 35(13), 2491–2501 (2010). · DOI
- Schulz KF. Subverting randomization in controlled trials. JAMA 274(18), 1456–1458 (1995). · DOI · Paper page
- North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N. Engl. J. Med. 325(7), 445–453 (1991). · DOI · Paper page
- Wennberg DE, Lucas FL, Birkmeyer JD, Bredenberg CE, Fisher ES. Variation in carotid endarterectomy mortality in the Medicare population: trial hospitals, volume, and patient characteristics. JAMA 279(16), 1278–1281 (1998). · DOI · Paper page
- Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA 290(12), 1624–1632 (2003). · DOI
Cited by
Attention-deficit/hyperactivity disorder
Faraone, S. V., Asherson, P., Banaschewski, T., Biederman, J., Buitelaar, J. K., Ramos-Quiroga, J. A., Rohde, L. A., Sonuga-Barke, E. J. S., Tannock, R., & Franke, B. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.20 · Cited by 1,479
Luedtke, A., Sadikova, E., & Kessler, R. C. (2019) · Clinical Psychological Science · doi:10.1177/2167702618815466 · Cited by 143
Agar, M., Luckett, T., Luscombe, G., Phillips, J., Beattie, E., Pond, D., Mitchell, G., Davidson, P. M., Cook, J., Brooks, D., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0181020 · Cited by 74
Bossie, C. A., Alphs, L. D., & Correll, C. U. (2015) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000082 · Cited by 33
Drawing causal inferences from randomized controlled trials in psychotherapy research
Kazdin, A. E. (2023) · Psychotherapy Research · doi:10.1080/10503307.2022.2130112 · Cited by 16
“This variation of an RCT evaluates how effective an intervention is in routine, everyday clinical practice (Lurie & Morgan, 2013; MacPherson, 2004; Newman et al., 2021).”
Background
Metadata
- Authors
- Lurie, J. D., & Morgan, T. S.
- Venue
- Journal of Comparative Effectiveness Research
- Publisher
- Becaris Publishing Limited
- Published
- 2013-01
- Volume
- 2
- Issue
- 1
- Pages
- 53-58
- ISSN
- 2042-6305 (ISSN-L)
- 2042-6313
- OpenAlex
- W2109993319
- Cited by
- 57
- References
- 5
- FWCI
- 3.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.